PharSafer

PharSafer

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

PharSafer is a privately-held, revenue-generating service provider in the pharmacovigilance and drug safety sector. The company offers a comprehensive 'one-stop-shop' suite of services, including case processing, regulatory strategy, auditing, training, and IT informatics, effectively acting as an external pharmacovigilance department for its clients. With a strong track record evidenced by over 75 client audits and engagements in over 100 inspections, it emphasizes high-quality service, boasting 97-99% case accuracy and compliance rates. Its long-term client relationships, many lasting over 10 years, and its integrated training platform via sister company SaPhar, form the core of its value proposition.

PharmacovigilanceDrug Safety

Technology Platform

Integrated pharmacovigilance service delivery framework supported by proprietary training platform (SaPhar) for employee and client education, robust quality management systems, and IT informatics for safety data processing.

Funding History

1
SeedUndisclosed

Opportunities

Growing regulatory complexity and the rise of virtual biotech firms drive demand for outsourced pharmacovigilance expertise.
Expansion into emerging markets with new safety regulations presents additional service opportunities.
The increasing use of Real-World Evidence (RWE) and AI in drug development creates a need for specialized compliance support in these evolving areas.

Risk Factors

Intense competition from large global CROs and other PV specialists could pressure pricing and client retention.
The business is highly reliant on maintaining flawless quality and compliance; a single significant operational failure could severely damage its reputation.
Dependency on key personnel and the competitive labor market for PV experts poses a human capital risk.

Competitive Landscape

PharSafer competes in the pharmacovigilance outsourcing market against large, full-service global CROs (e.g., IQVIA, ICON) and other specialized PV service providers. Its differentiation is based on a high-touch, quality-focused, and long-term partnership model, contrasting with the potentially more transactional approach of larger players. The integrated training offering via SaPhar is a unique competitive asset.